Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX).
- Disclosed ownership: 5.2%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 5.2% ownership in Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.7% | 729,856 | 0 | 729,856 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.7% | 729,856 | 0 | 729,856 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.1% | 578,633 | 0 | 578,633 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.1% | 578,633 | 0 | 578,633 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 77,407 | 0 | 77,407 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 77,407 | 0 | 77,407 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4.8% | 1,308,489 | 0 | 1,308,489 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 5.2% | 1,414,165 | 0 | 1,414,165 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 5.2% | 1,414,165 | 0 | 1,414,165 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 5.2% | 1,414,165 | 0 | 1,414,165 | /s/ Mark N. Lampert | Mark N. Lampert |